ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Aug 15, 2017 10:07 JST
Source:
PuraPharm Corporation Limited
PuraPharm Announces Acquisition of Japanese Health Products Company SODX
Expands Health Food Business Leveraging Advanced Japanese Technology
HONG KONG, Aug 15, 2017 - (ACN Newswire) - PuraPharm Corporation Limited ("PuraPharm" or the "Group", HKEX: 1498), a leading Hong Kong-based Chinese medicine company, has announced that it entered into share purchase agreements through its Japanese subsidiary to acquire SODX Co., Ltd. ("SODX"), a Japan-based company that principally engages in the manufacturing and sale of health food in Japan, at a total consideration of JPY244.0 million (equivalent to approximately HK$17.1 million). Upon completion of the acquisition, SODX will become an indirect wholly-owned subsidiary of the Group.
Based in Izumi City, Osaka, Japan, SODX is certified by the Japanese Institute for Health Food Standards as Good Manufacturing Practice ("GMP") health products manufacturer that produces its own branded products as well as manufactures health products and packaging specified by its customers. It specialises in producing dietary supplement products using fermented soybeans and antioxidant products. SODX is also recognised for developing patented products, including health food product that contains thrombolytic enzyme. SODX has received widespread recognition and support from the health food products industry due to its high-quality products, capability of making various dosage forms and advanced equipment for product packaging.
The acquisition will provide PuraPharm with a cost- and time-effective means of developing its health food business, leveraging SODX's expertise and resources. SODX's factory will serve as a pilot factory to transfer the latest technological know-how from Japan to further improve the quality and production efficiency of PuraPharm's Chinese healthcare products. The pilot factory will also act as the Group's new product development centre for business expansion.
Mr. Abraham Chan, Founder, Chairman, Chief Executive Officer and Executive Director of PuraPharm, said, "I am delighted to announce the acquisition of SODX, which gives us immediate access to state-of-the-art technology used for Japanese health products. This will not only complement our existing healthcare product portfolio, but will also further improve our product quality; enabling us to raise our competitiveness in the market."
About PuraPharm Corporation Limited
PuraPharm is a leading Hong Kong-based Chinese medicine company specialising in the research and development, production and sale of CCMG products which the Group markets under its "Nong's" brand. PuraPharm is the largest supplier of CCMG products in Hong Kong with a market share of 70% in terms of prescription revenue for the Hong Kong CCMG product market in 2014, according to the Euromonitor Report. The Group also sells a broad range of general Chinese healthcare products, such as PuraGold and Oncozac, which are essentially Chinese herbal supplements, on an OTC basis, targeting end-consumers. PuraPharm operates the largest Chinese medicine clinic chain in Hong Kong. PuraPharm's shares have been listed on the Main Board of the Stock Exchange of Hong Kong Limited since 8 July 2015 under the stock code 1498.
Media Enquiries:
Strategic Financial Relations Limited
Heidi So +852 2864 4826
heidi.so@sprg.com.hk
Fanny Yuen +852 2864 4853
fanny.yuen@sprg.com.hk
Jessica Siu +852 2114 2820
jessica.siu@sprg.com.hk
www.sprg.com.hk
Source: PuraPharm Corporation Limited
Sectors: Food & Beverage, Daily News, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
MHI Concludes Positive Impact Finance Agreement
Mar 29, 2024 19:20 JST
Panasonic Energy and Mazda Enter Agreement Towards Supply of Cylindrical Automotive Lithium-ion Batteries
Mar 29, 2024 17:42 JST
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
Mar 29, 2024 15:51 JST
Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture
Mar 29, 2024 15:19 JST
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
Mar 29, 2024 14:32 JST
Fujitsu Selected as CDP Supplier Engagement Leader
Mar 29, 2024 10:28 JST
Mazda Production and Sales Results for February 2024
Mar 29, 2024 10:00 JST
Mitsubishi Shipbuilding Receives Order from the University of Tokyo for "MiPoLin" Power Prediction and Lines Selection System
Mar 28, 2024 16:45 JST
Mitsubishi Logisnext Completes Demonstration of Automated Truck Loading, Leading to Start of Actual Operations in Japan
Mar 28, 2024 13:52 JST
Toyota Releases Sales, Production, and Export Results for February 2024
Mar 28, 2024 13:35 JST
TANAKA to Install 500 kW Fuel Cell System to Promote the Use of Hydrogen Energy at Production Plants
Mar 28, 2024 03:00 JST
PEVE to change name to TOYOTA BATTERY Co., Ltd. and produce batteries for a wide range of electric vehicles
Mar 27, 2024 15:13 JST
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
Mar 27, 2024 15:00 JST
TANAKA Holdings Announces Green Loan Financing for Construction of New Head Office Building
Mar 27, 2024 03:00 JST
JFE Steel and Hitachi Jointly Started Providing Solutions for the Steel Industry
Mar 26, 2024 19:04 JST
La Banque Postale and JCB join forces to elevate payments experience for travellers in France
Mar 26, 2024 15:00 JST
Fujitsu Tech Leverages AI and Underwater Drone Data for 'Ocean Digital Twin'
Mar 26, 2024 10:24 JST
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
Mar 25, 2024 10:08 JST
Toyota to Open New Tokyo Head Office in Shinagawa in FY2030
Mar 22, 2024 16:15 JST
Hitachi Selected as CDP Supplier Engagement Leader for the Third Consecutive Year
Mar 22, 2024 16:04 JST
More Latest Release >>
Related Release
PuraPharm Opens Its First-ever Nong's Chinese Medicine Clinic in Mainland China
August 02 2017 18:31 JST
PuraPharm Announces the Acquisition of K'An Herb
March 06 2017 09:21 JST
PuraPharm Shareholders Unanimously Votes for Acquisition of Companies Planting and Trading Raw Chinese Herbs and Manufacturing and Selling TCM Decoction Pieces
January 18 2017 19:26 JST
Mr. Abraham Chan, Founder, Chairman, CEO and Executive Director of PuraPharm Garners "Directors of the Year Awards 2016" from The Hong Kong Institute of Directors
December 07 2016 15:02 JST
PuraPharm Wins Corporate Achievement Award at Outstanding Import & Export Enterprise Awards 2016
October 19 2016 15:30 JST
PuraPharm Achieves Goal of Opening 30 Nong's Clinics in Hong Kong by End of 2015
December 28 2015 20:14 JST
PuraPharm Appoints Heilongjiang ZBD Pharma as its Exclusive Distributor for its CCMG Products in Five Provinces in China
November 23 2015 19:32 JST
PuraPharm Opens Its 20th Nong's Clinic in Hong Kong
October 22 2015 17:29 JST
More Press release >>